Suppr超能文献

持续非卧床腹膜透析期间头孢噻肟和去乙酰头孢噻肟的处置情况

Disposition of cefotaxime and desacetyl cefotaxime during continuous ambulatory peritoneal dialysis.

作者信息

Heim K L, Halstenson C E, Comty C M, Affrime M B, Matzke G R

出版信息

Antimicrob Agents Chemother. 1986 Jul;30(1):15-9. doi: 10.1128/AAC.30.1.15.

Abstract

The disposition of cefotaxime (CTX) and desacetyl cefotaxime (DAC) was studied in eight noninfected patients on continuous ambulatory peritoneal dialysis. Each patient received a single intravenous (i.v.) infusion and an intraperitoneal (i.p.) instillation of 2 g of CTX. Multiple blood and dialysate samples were collected during the 72-h period after drug administration. The half-life, steady-state volume of distribution, and total body clearance of CTX following i.v. administration were 2.2 +/- 1.0 h (mean +/- standard deviation), 0.17 +/- 0.03 liters/kg, and 81.0 +/- 31.0 ml/min, respectively. No significant differences were observed in these parameters after i.p. administration. The continuous ambulatory peritoneal dialysis clearances of CTX and DAC were 1.82 +/- 0.43 and 2.84 +/- 0.70 ml/min, respectively, after i.v. administration. The bioavailability of CTX after i.p. instillation was 74.6 +/- 21.3%. Peak peritoneal dialysate CTX and DAC concentrations of 264.3 and 25.8 mg/liter, respectively, were observed after i.p. dosing. Administration (i.v.) of 2 g every 12 h or i.p. instillation of 2 g every 24 h may be used for the treatment of i.p. infections with highly susceptible organisms (MIC less than 1.0 microgram/ml).

摘要

在8例持续非卧床腹膜透析的非感染患者中研究了头孢噻肟(CTX)和去乙酰头孢噻肟(DAC)的处置情况。每位患者接受单次静脉注射和2g CTX的腹腔内滴注。给药后72小时内采集多份血液和透析液样本。静脉给药后,CTX的半衰期、稳态分布容积和全身清除率分别为2.2±1.0小时(平均值±标准差)、0.17±0.03升/千克和81.0±31.0毫升/分钟。腹腔给药后这些参数未观察到显著差异。静脉给药后,CTX和DAC的持续非卧床腹膜透析清除率分别为1.82±0.43和2.84±0.70毫升/分钟。腹腔内滴注后CTX的生物利用度为74.6±21.3%。腹腔给药后观察到腹膜透析液中CTX和DAC的峰值浓度分别为264.3和25.8毫克/升。每12小时静脉注射2g或每24小时腹腔内滴注2g可用于治疗对高度敏感菌(MIC小于1.0微克/毫升)的腹腔感染。

相似文献

1
Disposition of cefotaxime and desacetyl cefotaxime during continuous ambulatory peritoneal dialysis.
Antimicrob Agents Chemother. 1986 Jul;30(1):15-9. doi: 10.1128/AAC.30.1.15.
2
Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Clin Pharmacol Ther. 1985 Sep;38(3):285-9. doi: 10.1038/clpt.1985.172.
3
Cefotaxime and metabolite disposition in two pediatric continuous ambulatory peritoneal dialysis patients.
Ann Pharmacother. 1992 Mar;26(3):341-3. doi: 10.1177/106002809202600307.
4
Pharmacokinetics of cefodizime during continuous ambulatory peritoneal dialysis.
J Antimicrob Chemother. 1990 Nov;26 Suppl C:89-93. doi: 10.1093/jac/26.suppl_c.89.
5
Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
Antimicrob Agents Chemother. 1983 Aug;24(2):237-9. doi: 10.1128/AAC.24.2.237.
6
Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.
Eur J Clin Pharmacol. 1986;30(6):713-7. doi: 10.1007/BF00608221.
7
Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.
J Antimicrob Chemother. 1984 Sep;14 Suppl B:135-42. doi: 10.1093/jac/14.suppl_b.135.

本文引用的文献

2
Trimethoprim alone for treatment of urinary tract infection.
Rev Infect Dis. 1982 Mar-Apr;4(2):366-71. doi: 10.1093/clinids/4.2.366.
3
Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis.
Clin Pharmacol Ther. 1983 Jan;33(1):66-72. doi: 10.1038/clpt.1983.9.
4
Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
Antimicrob Agents Chemother. 1983 Aug;24(2):237-9. doi: 10.1128/AAC.24.2.237.
6
Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease.
Antimicrob Agents Chemother. 1981 Apr;19(4):526-31. doi: 10.1128/AAC.19.4.526.
7
Metabolism of cefotaxime in animals and man.
J Antimicrob Chemother. 1980 Sep;6 Suppl A:69-78. doi: 10.1093/jac/6.suppl_a.69.
8
Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Clin Pharmacol Ther. 1985 Sep;38(3):285-9. doi: 10.1038/clpt.1985.172.
9
Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
Clin Pharmacol Ther. 1985 Jul;38(1):31-6. doi: 10.1038/clpt.1985.130.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验